Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;22(4):325-331.
doi: 10.7861/clinmed.2022-0112.

Inpatient hyperglycaemia, and impact on morbidity, mortality and re-hospitalisation rates

Affiliations

Inpatient hyperglycaemia, and impact on morbidity, mortality and re-hospitalisation rates

Yvette Farrugia et al. Clin Med (Lond). 2022 Jul.

Abstract

Introduction: Hyperglycaemia is related to poorer outcomes among hospital inpatients. We investigated the impact of hyperglycaemia at admission on length of hospital stay, readmission rate and mortality rate.

Method: We retrospectively analysed the records of 1,132 patients admitted to hospital in January 2019, April 2019, August 2019 and April 2020.

Results: Hyperglycaemia was present in 14.1% of patients. New-onset hyperglycaemia on admission (in 3.9% of patients) was related to a higher mortality rate than in patients known to have diabetes admitted with hyperglycaemia (43.3% vs 17.9%; p=0.006). Mortality at 90 days and 1 year increased with higher admission glucose levels (p=0.03 and p=0.005, respectively), severe hyperglycaemia (>20 mmol/L) having a 1-year mortality of 34.3%. After accounting for confounding variables, admission glucose and length of stay remained significant predictors of 1-year mortality (p=0.034 and p=0.003, respectively).

Conclusion: Hyperglycaemia is an important prognostic marker and may indicate a more severe illness. These patients should be highlighted for a greater level of care.

Keywords: diabetes mellitus; hyperglycaemia; morbidity; mortality.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Plasma glucose on admission related with mortality at 1 year and re-hospitalisation at 1 year.

References

    1. Government of Malta . Diabetes: A national public health priority. Government of Malta, 2016. https://deputyprimeminister.gov.mt/en/Documents/National-Health-Strategi... [Accessed 03 March 2022].
    1. Campbell RK. Etiology and effect on outcomes of hyperglycemia in hospitalized patients. Am J Health Syst Pharm 2007;64 (10 Suppl 6):S4–8. - PubMed
    1. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978–82. - PubMed
    1. Norhammar AM, Rydén L, Malmberg K. Admission plasma glucose. Independent Risk Factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999;22:1827–31. - PubMed
    1. Evans NR, Dhatariya KK. Assessing the relationship between admission glucose levels, subsequent length of hospital stay, readmission and mortality. Clin Med 2012;12:137–9. - PMC - PubMed